Wednesday, November 11, 2009

The Mulligan Law Firm is Investigating Injury Claims: Diabetes Drug Byetta� Linked to Kidney-Related Side Effects and Acute Renal Failure

The Mulligan Law Firm is investigating Byetta® injury claims. On November 2nd the FDA released a MedWatch Safety Alert detailing 78 cases of altered kidney function (62 cases of acute renal failure and 16 cases of renal insufficiency), in patients using Byetta®. Some cases occurred in patients with pre-existing kidney disease or in patients with one or more risk factors for developing kidney problems

Dallas, TX (PRWEB) November 11, 2009 -- The Mulligan Law Firm is investigating Byetta® injury claims. "From April 2005 through October 2008, the FDA received 78 cases of altered kidney function (62 cases of acute renal failure and 16 cases of renal insufficiency), in patients using Byetta®. Some cases occurred in patients with pre-existing kidney disease or in patients with one or more risk factors for developing kidney problems ..." -- From the Food and Drug Administration MedWatch Safety Alert, November 2, 2009.

Byetta® (marketed as exenatide) is manufactured by Amylin Pharmaceuticals, Inc., and was prescribed nearly 7 million times between April 2005 and September 2008.A diabetes medicine, Byetta is administered through injection. The medicine works to help control blood sugar levels by increasing the ability of the pancreas to produce insulin. Used to treat type 2 diabetes, Byetta® is approved as an adjunct to diet and exercise.

Worldwide, 90% of diabetics have Type 2 diabetes, which develops later in life than Type 1 and is often associated with excess weight. There are an estimated 200 million people with diabetes. In its early stages, Type 2 diabetes can be controlled through diet and exercise.

Byetta® and the Possible Link to Altered Kidney Function and Renal Failure
On November 2, 2009, the FDA issued a MedWatch Safety Alert, when reports of altered kidney function in patients using Byetta® increased. Concerned, the FDA immediately approved revisions to the drug label of Byetta® to warn of the potential risks.

Of the 78 patients in the cases the FDA gathered from April 2005 through October 2008, side-effects of nausea, vomiting, and diarrhea were most common. These were also the most common side effects linked to Byetta® in clinical trials. Byetta® may have contributed to the development of altered kidney function in the reported cases.

Per the FDA's November 2 release, the following side effects have also been potentially attributed to the use of Byetta®:

 
  • Death
  • Kidney Dysfunction
  • Renal Failure
  • Pancreatitis

If you or a loved one have been prescribed Byetta® and now are diagnosed with altered kidney function, renal failure, or pancreatitis, please contact The Mulligan Law Firm immediately for a free consultation.

Always consult with your physician before you stop taking any medications, including Byetta®.

The Mulligan Law Firm provides legal information and resources for injured individuals and their families. A national law firm located in Dallas, Texas, and Newport Beach, California, The Mulligan Law Firm has successfully resolved over $600,000,000 in claims for its clients. Formed in 1995, it has been helping people for almost 15 years, with the experience and strength to represent plaintiffs in all 50 states.

The Mulligan Law Firm is currently investigating injury claims involving Byetta®.

If you or a loved one has been diagnosed with altered kidney function, renal failure, or pancreatitis after taking Byetta®, please get in touch with us immediately for a free consultation - contact Eric Gruenwald, Attorney at (866) 529-0001, Ext. 245. The Mulligan Firm has experienced lawyers ready to help.

All cases are taken on a contingency-fee basis, which means the client does not pay for our services unless an award or compensation is received.

See Also:

[Via Legal / Law]

Posted by prolink at 1:45 AM

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)